Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 16/20 | 0.38 |
| ▸ | LATS1 | O95835 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | STK17B | O94768 | 1/20 | 0.33 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526567 | 0.82 | AAK1 (0.35) | AAK1LATS1PIK3CD | |
| SCHEMBL33527411 | 0.81 | AAK1 (0.38) | AAK1LATS1PIK3CDSTK17BSTK17A | |
| SCHEMBL33526681 | 0.80 | AAK1 (0.37) | AAK1LATS1PIK3CD | |
| SCHEMBL33526442 | 0.80 | AAK1 (0.37) | AAK1LATS1PIK3CD | |
| SCHEMBL33526401 | 0.78 | HDAC3 (0.39) | AAK1PIK3CD | |
| SCHEMBL33526962 | 0.77 | AAK1 (0.38) | AAK1LATS1STK17BSTK17A | |
| SCHEMBL33526462 | 0.77 | AAK1 (0.36) | AAK1PIK3CD | |
| Hydrochloric Acid SCHEMBL33525871 | 0.72 | NR3C2 (0.32) | NR3C2 | |
| SCHEMBL34466824 | 0.70 | HDAC3 (0.41) | AAK1 | |
| SCHEMBL16402351 | 0.68 | CYP3A4 (0.35) | AAK1LATS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | AAK1 2749/4885LATS1 3736/4885PIK3CD 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.